Published on 27 Apr 2022 on ETF DAILY NEWS
StockNews.com Begins Coverage on BIOLASE (NASDAQ:BIOL)
The firm set a “hold” rating on the medical technology company’sstock. Other equities analysts have...
NASDAQ.BIOL price evolution
Want to become a better investor?
Start tracking your investments with Statfolio
Sign up for free